Richard E. Kolinski - Concepedia

Author

Richard E. Kolinski

United States Food and Drug Administration

Also Known As

R E Kolinski, R. Kolinski, Richard E Kolinski, Richard E. Kolinski, Richard Kolinski, Richard. Kolinski

Publications

584

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Center for Drug Evaluation and Research

About

Richard E. Kolinski is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and drug analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	566
2	Biochemistry	7	7	302
3	Natural Sciences	3	3	96
4	Biomolecular Engineering	1	1	34
5	Chemical Biology	1	1	32

Richard E. Kolinski

Publications

566

Citations

H-Index

Page 1

	Year	Citations
Topical drug classification Lucinda F. Buhse, Richard E. Kolinski, Benjamin J. Westenberger, International Journal of Pharmaceutics Topical Drug ClassificationMedicinal ChemistryMedicineTopical DrugDermatology	2005	109
Analysis of heparin sodium by SAX/HPLC for contaminants and impurities Michael L. Trehy, John C. Reepmeyer, Richard E. Kolinski, Journal of Pharmaceutical and Biomedical Analysis Heparin SodiumBiochemistryMedicineBioanalysisMass Spectrometry	2008	81
Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques Benjamin J. Westenberger, Christopher D. Ellison, Andrew S. Fussner, International Journal of Pharmaceutics Medicinal ChemistryNon-traditional Analytical TechniquesInternet Pharmaceutical ProductsMedicineDrug Discovery	2005	80
Analysis of crude heparin by 1H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate David A. Keire, Michael L. Trehy, John C. Reepmeyer, Journal of Pharmaceutical and Biomedical Analysis Capillary ElectrophoresisBiochemistrySeparation ScienceMedicineBioanalysis	2009	63
Characterization of currently marketed heparin products: key tests for quality assurance David A. Keire, Hongping Ye, Michael L. Trehy, Analytical and Bioanalytical Chemistry Quality AssuranceHepatologyKey TestsHepatitisHeparin Products	2010	42
Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches David A. Keire, Daniel J. Mans, Hongping Ye, Journal of Pharmaceutical and Biomedical Analysis Anticoagulation Time ApproachesMotivated AdditivesBiochemistryMedicineNative Impurities Levels	2010	39
Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns Cynthia D. Sommers, Hongping Ye, Richard E. Kolinski, Analytical and Bioanalytical Chemistry BiochemistryNatural SciencesLiver PhysiologyBioanalysisGlycobiology	2011	34
Characterization of currently marketed heparin products: Key tests for LMWH quality assurance Hongping Ye, Timothy K. Toby, Cynthia D. Sommers, Journal of Pharmaceutical and Biomedical Analysis HepatologyKey TestsHepatitisHeparin ProductsLmwh Quality Assurance	2013	33
Phosphorescence of oligopeptides containing tryptophan and tyrosine Robert F. Steiner, Richard E. Kolinski Biochemistry Altmetric Attention ScoreSecondary MetaboliteBibliometricsPeptide ScienceChemical Biology	1968	32
Combining NMR Spectroscopy and Chemometrics to Monitor Structural Features of Crude Hep-arin Lucio Mauri, Maria Marinozzi, Giulia Mazzini, Molecules Nmr SpectroscopyFood AnalysisGlycobiologyMagnetic ResonanceCrude Hep-arin	2017	30

Page 1